CL
Clene Inc.
CLNNW · NASDAQ
$0.00 -28.00% (-$0.00)
Market Cap $2.16M
P/E Ratio -
Div. Yield -
ROE 351.16%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 10.11x
PEG N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Op. margin 11,328.50%
Gross margin 82.24%
FCF margin 8,694.91%
Quality
30 /100
Poor ROA 136.69%
ROIC 151.07%
Asset turnover 0.01x
Debt
66 /100
Moderate Net debt/EBITDA -0.51x
Current ratio 1.53x
Int. coverage -11.44x
Stability
55 /100
Moderate Profitable years 0
Beta 0.79x
EPS volatility 46.31%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CLNNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert Etherington
Employees
75
Headquarters
Salt Lake City